Citations

Showing 10 of 108094 citations.

Patient Engagement in Health Coaching and Self-Management Abilities in Chronic Obstructive Pulmonary Disease
Benzo, M.V. , Kelpin, Sydney S., Werneburg, Brooke L., Hoult, Johanna, Clark, Matthew M. , Novotny, Paul J. , Benzo, Roberto , Benzo, Maria V , Werneburg, Brooke, Novotny, Paul

Mayo Clinic

American Journal of Lifestyle Medicine | August 25, 2022 | Volume: 18 | Issue: 2 | Pages: 243-251

10.1177/15598276221120523 | PMID 38559791 Get It

Objective: Health coaching has the potential to improve self-management abilities (SM) in patients with Chronic Obstructive Pulmonary Disease (COPD). Patient engagement with health care providers has a beneficial effect on patient outcomes. We examined the association of patient engagement with the health coach on SM abilities in patients with COPD. Methods: We analyzed the association between the degree of engagement measured by the Working Alliance Inventory (WAI-SR) and the SM measured by the Self-Management-Ability-Scale-30 (SMAS-30) at the end of a COPD health coaching intervention. Results: The cohort included 146 moderate to severe COPD patients. The WAI-SR total score was 85% of the maximum possible scores indicating a high degree of engagement between the health coach and the patients. The WAI-SR Task and Bond domains were positively associated with SM abilities after adjusting for lung function (FEV1 %) and depression symptoms (PHQ-2). Conclusion: The degree of engagement between a health coach and patients is associated with the perception of SM abilities in patients with COPD. Our results may inform self-management intervention and clinical practice.
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study
Melsens, Karin , Schonenberg‐Meinema, Dieneke , Leone, Maria Comasia, Mostmans, Yora , Badot, Valérie, Cimaz, Rolando , Dehoorne, Joke , Deschepper, Ellen , Hernández‐Zapata, Johanna , Khan, Archana , Lehmann, Hartwig , Müller‐Ladner, Ulf , Nuño, Laura , Overbury, Rebecca S. , Pizzorni, Carmen , Radić, Mislav , Ramadoss, Divya , Berg, Merlijn J van den, Herrick, Ariane L. , Diseases, for the EULAR Study Group on Microcirculation in Rheumatic, Deroo, Liselotte , Bergkamp, Sandy C. , Nassar-Sheikh-Rashid, Amara, Elisa, Patrone, Hermann, W., Bica, Francesco, Cattelan, Francesco, Gattinara, M., Özcan, Zeynep , Murías, Sara , Alcobendas, Rosa , Remesal, A. Vega, Pimpale, Pallavi, Khubchandani, Raju , Ingegnoli, Francesca , Michalska-Jakubus, Malgorzata , Herrick, Ariane L , Sulli, Alberto , Smith, Vanessa , Cutolo, Maurizio , Foeldvari, Ivan , Frech, Tracy , Ingegnoli, Francesca , Krasowska, Dorota , Makol, Ashima , Navas, Miguel Antonio Mesa , Ravelli, Angelo , Rosina, Silvia , Udaondo, Clara , Diseases, for the EULAR Study Group on Microcirculation in Rheumatic, Vanhaecke, Amber , Özcan, Zeynep, Remesal, Augustin, Pimpale, Pallavi

Mayo Clinic

Rheumatology | August 25, 2022 | Volume: 62 | Issue: 4 | Pages: 1605-1615

10.1093/rheumatology/keac487 | PMID 36005889 Get It

AbstractObjectivesTo standardly assess and describe nailfold videocapillaroscopy (NVC) assessment in children and adolescents with juvenile rheumatic and musculoskeletal diseases (jRMD) vs healthy controls (HCs).Material and methodsIn consecutive jRMD children and matched HCs from 13 centres worldwide, 16 NVC images per patient were acquired locally and read centrally per international consensus standard evaluation of the EULAR Study Group on Microcirculation in Rheumatic Diseases. A total of 95 patients with JIA, 22 with JDM, 20 with childhood-onset SLE (cSLE), 13 with juvenile SSc (jSSc), 21 with localized scleroderma (lSc), 18 with MCTD and 20 with primary RP (PRP) were included. NVC differences between juvenile subgroups and HCs were calculated through multivariable regression analysis.ResultsA total of 6474 images were assessed from 413 subjects (mean age 12.1 years, 70.9% female). The quantitative NVC characteristics were significantly lower or higher in the following subgroups compared with HCs: for density: lower in jSSc, JDM, MCTD, cSLE and lSc; for dilations: higher in jSSc, MCTD and JDM; for abnormal shapes: higher in JDM and MCTD; for haemorrhages: higher in jSSc, MCTD, JDM and cSLE. The qualitative NVC assessment of JIA, lSc and PRP did not differ from HCs, whereas the cSLE and jSSc, MCTD, JDM and cSLE subgroups showed more non-specific and scleroderma patterns, respectively.ConclusionsThis analysis resulted from a pioneering registry of NVC in jRMD. The NVC assessment in jRMD differed significantly from HCs. Future prospective follow-up will further elucidate the role of NVC in jRMD.
Pleomorphic Liposarcoma
Gjeorgjievski, Sandra Gjorgova , Thway, Khin , Fisher, Cyril , Jenkins, Sarah M. , Thangaiah, Judith Jebastin, Folpe, Andrew L. , Fritchie, Karen , Gjorgova Gjeorgjievski, Sandra , Thangaiah, Judith J., Dermawan, Josephine K. , John, Ivy , Rubin, Brian P.

Mayo Clinic

American Journal of Surgical Pathology | August 25, 2022 | Volume: 46 | Issue: 12 | Pages: 1700-1705

10.1097/pas.0000000000001962 | PMID 36006773 Get It

Pleomorphic liposarcoma (PLPS) is a highly aggressive sarcoma comprising variable numbers of pleomorphic lipoblasts mixed with undifferentiated pleomorphic sarcoma (UPS)-like areas. Morphologic variants, such as myxofibrosarcoma-like or epithelioid, may cause diagnostic confusion, especially on a core biopsy, but there are few data on the prognostic significance of these features. A total of 120 PLPS biopsies and resection specimens were reviewed and catalogued based on the presence of myxofibrosarcoma-like, UPS-like, and epithelioid foci, in 10% increments. The clinical parameters were collected. Cases occurred in 75 males and 45 females, ranging from 8 to 98 years (median, 62.5 y). Cases arose in the extremities (n=72), trunk (n=32), head/neck (n=10), bone (n=4), mediastinum (n=1), or viscera (colon polyp, n=1). Of those with known depth (n=81), 40 were intramuscular, 34 were subcutaneous, and 7 arose in the dermis. Their sizes ranged from 1 to 24.5 cm (median, 7 cm). Of the patients with ≥1 month of follow-up (n=70), 5 had recurrence and 15 had metastasis. The 5-year overall survival and event-free survival rates were 66.2% and 63.1%, respectively. Tumors ≥5 cm had inferior overall survival compared with tumors <5 cm. The presence of epithelioid areas was also statistically significant in terms of poorer overall survival and event-free survival, while tumors with ≥50% undifferentiated pleomorphic-like areas had better overall survival. There was a trend towards poorer outcomes in tumors with necrosis (≥1%). PLPS is an aggressive adipocytic malignancy that is most commonly present in the extremities of older adults. The morphologic features of these tumors are diverse, and they may be mistaken for UPS or myxofibrosarcoma, carcinoma, and melanomas, particularly on biopsies. Tumor size, necrosis, and epithelioid morphology are associated with adverse prognosis.
Hyena Bite Injury to the Neck Leading to Laryngotracheal Separation
Macielak, Robert J. , Temam, Seid, Wiedermann, Joshua P. , Green, Katerina

Mayo Clinic

AMERICAN JOURNAL OF SURGERY CASE REPORTS | August 25, 2022 | Volume: No volume available | Issue: No issue available | Pages: 1-4

10.47496/sl.ajscr.2022.01.01 Get It

Animal-induced trauma can lead to severe injury and death, especially in medically isolated settings. Few reports of hyena attacks on humans have been reported in the literature. The goal of this report is to describe such an attack and the heroic efforts required to preserve life and function in a resource-limited environment. We present a case of a 55-year-old female who was attacked by a hyena in a rural region of Ethiopia. Despite delays in medical care, she was able to survive this attack and was successfully discharged after prolonged treatment efforts. Animal-induced trauma is a potential source of substantial and disfiguring injury – especially in resource-limited environments. Early transfer to tertiary care centers and creative solutions are needed to optimize outcomes in such environments.
Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
Camm, C Fielder , Virdone, Saverio , Goto, Shinya , Bassand, Jean‐Pierre , Eickels, Martin van, Haas, Sylvia , Pieper, Karen S. , Misselwitz, Frank , Turpie, Alexander G.G., Goldhaber, Samuel Z. , Verheugt, Freek W.A., Camm, A. John , Kayani, Gloria , Панченко, Е. П. , Luciardi, Héctor, Sawhney, J.P.S. , Connolly, Stuart J. , Angchaisuksiri, Pantep , Kakkar, Ajay K. , Gersh, Bernard J. , Fox, Keith A.A. , Oh, Seil , Cate, Hugo Ten , Eikelboom, John W.

Mayo Clinic

Open Heart | August 25, 2022 | Volume: 9 | Issue: 2 | Pages: e002038

10.1136/openhrt-2022-002038 Get It

Objective While greater body mass index (BMI) is associated with increased risk of developing atrial fibrillation (AF), the impact of BMI on outcomes in newly diagnosed AF is unclear. We examine the influence of BMI on outcomes and whether this is modified by sex and evaluate the effect of non-vitamin K oral anticoagulants (NOACs) in patients with high BMI. Methods GARFIELD-AF is a prospective registry of 52 057 newly diagnosed AF patients. The study population comprised 40 482 participants: 703 underweight (BMI <18.5 kg/m 2 ), 13 095 normal (BMI=18.5–24.9 kg/m 2 ), 15 043 overweight (BMI=25.0–29.9 kg/m 2 ), 7560 obese (BMI=30.0–34.9 kg/m 2 ) and 4081 extremely obese (BMI ≥35.0 kg/m 2 ). Restricted cubic splines quantified the association of BMI with outcomes. Comparative effectiveness of NOACs and vitamin K antagonists (VKAs) by BMI was performed using propensity score overlap-weighted Cox models. Results The median age of participants was 71.0 years (Q1; Q3 62.0; 78.0), and 55.6% were male. Those with high BMI were younger, more often had vascular disease, hypertension and diabetes. Within 2-year follow-up, a U-shaped relationship between BMI and all-cause mortality was observed, with BMI of ~30 kg/m 2 associated with the lowest risk. The association with new/worsening heart failure was similar. Only low BMI was associated with major bleeding and no association emerged for non-haemorrhagic stroke. BMI was similarly associated with outcomes in men and women. BMI did not impact the lower rate of all-cause mortality of NOACs compared with VKAs. Conclusions In the GARFIELD-AF registry, underweight and extremely obese AF patients have increased risk of mortality and new/worsening heart failure compared with normal or obese patients.
Natriuretic peptide pathways in heart failure: further therapeutic possibilities
Sangaralingham, S. Jeson , Kühn, Michaela , Cannone, Valentina , Chen, Horng H. , Burnett, John C. , Sangaralingham, S. Jeson

Mayo Clinic

Cardiovascular Research | August 25, 2022 | Volume: 118 | Issue: 18 | Pages: 3416-3433

10.1093/cvr/cvac125 | PMID 36004816 Get It

Abstract The discovery of the heart as an endocrine organ resulted in a remarkable recognition of the natriuretic peptide system (NPS). Specifically, research has established the production of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) from the heart, which exert pleiotropic cardiovascular, endocrine, renal, and metabolic actions via the particulate guanylyl cyclase A receptor (GC-A) and the second messenger, cGMP. C-type natriuretic peptide (CNP) is produced in the endothelium and kidney and mediates important protective auto/paracrine actions via GC-B and cGMP. These actions, in part, participate in the efficacy of sacubitril/valsartan in heart failure (HF) due to the augmentation of the NPS. Here, we will review important insights into the biology of the NPS, the role of precision medicine, and focus on the phenotypes of human genetic variants of ANP and BNP in the general population and the relevance to HF. We will also provide an update of the existence of NP deficiency states, including in HF, which provide the rationale for further therapeutics for the NPS. Finally, we will review the field of peptide engineering and the development of novel designer NPs for the treatment of HF. Notably, the recent discovery of a first-in-class small molecule GC-A enhancer, which is orally deliverable, will be highlighted. These innovative designer NPs and small molecule possess enhanced and novel properties for the treatment of HF and cardiovascular diseases.
Dietitian Involvement Improves Consumption of Oral Nutrition Supplements in Hospitalized Patients
Velapati, Saketh R. , Miller, Lisa D., Huiras, Michael F., Stoecker, Evan A., Warner, Morgan, Vanderveer, Laura, Adkins, Ashley, Chargo, Christopher, Kueny, Katherine, Bailey, Molly S., Mohamed Elfadil, Osman , Hurt, Ryan T. , Elfadil, Osman Mohamed , Mundi, Manpreet S.

Mayo Clinic

Canadian Journal of Dietetic Practice and Research | August 25, 2022 | Volume: 83 | Issue: 4 | Pages: 203-207

10.3148/cjdpr-2022-016 | PMID 36004724 Get It

Hospitalized patients are at an increased risk of malnutrition due to multiple factors including, but not limited to, acute and chronic diseases especially those affecting gastrointestinal tract, surgery, appetite, and frequent nil per os while undergoing diagnostic workup. Because of this, guidelines suggest the use of oral nutritional supplements (ONS) in hospitalized patients to reduce the risk of malnutrition and its complications. The current report aims to highlights key findings from a cross-sectional survey of 99 hospitalized patients who were at risk for or diagnosed with malnutrition and prescribed ONS. Data regarding ONS prescriber information as well as number ordered and consumed were collected. Of the 2.4 ± 1.5 supplements ordered per person each day, only 1.3 ± 1.1 were consumed, and there was 48% wastage of prescribed ONS. However, dietitian involvement was associated with significant reduction in wastage. Given the need and benefit, it is imperative for the nutrition community to further explore best practices to improve ONS consumption.
Isolation and Culture of Vascular Distal Outflow Pathway (VDOP) Cells From Human Donor Eyes
Chowdhury, Uttio Roy, Fautsch, Michael P. , Roy Chowdhury, Uttio

Mayo Clinic

Current Protocols | August 25, 2022 | Volume: 2 | Issue: 8 | Pages: No page available

10.1002/cpz1.528 | PMID 36005888 Get It

AbstractGlaucoma, a progressive neurodegenerative ocular disease, is the leading cause of irreversible blindness worldwide. Elevated intraocular pressure (IOP) is the most common—and the only treatable—risk factor for glaucoma. IOP is generated by the balance between production and removal of aqueous humor in the anterior part of the eye, and the latter happens either through the uveoscleral or the conventional pathway. Although both pathways are important for aqueous humor removal, dysfunction within the conventional pathway is more commonly associated with increased resistance leading to elevated IOP and glaucoma. The conventional pathway can be separated into proximal (trabecular meshwork and inner wall of Schlemm's canal) and distal (outer wall of Schlemm's canal, collector channels, and episcleral vasculature) regions. Both regions contribute resistance to aqueous humor removal, but the proximal region has been studied more extensively due to the availability of model systems. In contrast, little is known about the role of the distal region in outflow resistance, largely due to the lack of suitable in vitro models. To address this, we have developed a novel method of isolating and culturing vascular distal outflow pathway (VDOP) cells from the distal outflow region of human eyes. VDOP cells can be used to study the physiological and molecular functions of cells in the distal outflow region and can help in the development of ocular hypotensive drugs that specifically target this area. We also provide a protocol describing immunohistochemical methods to validate the molecular profile of these cells, utilizing cell surface markers that distinguish them from adjacent cells. © 2022 Wiley Periodicals LLC.Basic Protocol 1: Isolation and culture of VDOP cellsBasic Protocol 2: Analysis of cell surface markers
Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy
Farrell, Kurt , Iida, Megan A., Cherry, Jonathan D. , Casella, Alicia, Stein, Thor D. , Bieniek, Kevin F. , Richardson, Timothy E. , Alvarez, Victor E., Huber, Bertrand R. , Insausti, Ricardo , Group, The Part Working, Vonsattel, Jean‐Paul, Teich, Andy F, Gearing, Marla , Glass, Jonathan D. , Troncoso, Juan C. , Frosch, Matthew P. , Attems, Johannes , Mesulam, M-Marsel, Weıntraub, Sandra , Woltjer, Randy, Pham, Thao, Kofler, Julia , Yu, Lei , Purohit, Dushyant P. , Haroutunian, Vahram , Sano, Mary , Beach, Thomas G. , Kawas, Claudia H. , Metcalf, Jeff , Shuldberg, Sara, Salehi, Bahar , Nelson, Peter T. , Trojanowski, John Q. , Latimer, Caitlin S. , Montine, Thomas J. , Kovács, Gábor G. , Lutz, Mirjam I. , Perrin, Richard J. , Cairns, Nigel J. , McKee, Ann C. , Crary, John F. , Kovacs, Gabor G , Farrell, Kurt , Walker, Jamie M. , White, Charles L. , Dickson, Dennis W. , Dams-O’Connor, Kristen , Group, The Part Working, Teich, Andy F, Hyman, Bradley T. , Murray, Melissa E. , Flanagan, Margaret E. , Mao, Qinwen , Schneider, Julie A. , Yu, Lei , Hof, Patrick R. , Gandy, Sam , Poon, Wayne W. , Corrada, María M. , Rissman, Robert A. , Lee, Edward B. , Wolk, David A. , McMillan, Corey T. , Keene, C. Dirk , Fischer, Peter A.

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | August 25, 2022 | Volume: 81 | Issue: 10 | Pages: 781-789

10.1093/jnen/nlac066 | PMID 36004533 Get It

Abstract Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive mild head impacts characterized by perivascular hyperphosphorylated tau (p-tau) in neurofibrillary tangles (NFTs) and neurites in the depths of the neocortical sulci. In moderate to advanced CTE, NFTs accumulate in the hippocampus, potentially overlapping neuroanatomically with primary age-related tauopathy (PART), an age-related tauopathy characterized by Alzheimer disease-like tau pathology in the hippocampus devoid of amyloid plaques. We measured p-tau burden using positive-pixel counts on immunohistochemically stained and neuroanatomically segmented hippocampal tissue. Subjects with CTE had a higher total p-tau burden than PART subjects in all sectors (p = 0.005). Within groups, PART had significantly higher total p-tau burden in CA1/subiculum compared to CA3 (p = 0.02) and CA4 (p = 0.01) and total p-tau burden in CA2 trended higher than CA4 (p = 0.06). In CTE, total p-tau burden in CA1/subiculum was significantly higher than in the dentate gyrus; and CA2 also trended higher than dentate gyrus (p = 0.01, p = 0.06). When controlling for p-tau burden across the entire hippocampus, CA3 and CA4 had significantly higher p-tau burden in CTE than PART (p &lt; 0.0001). These data demonstrate differences in hippocampal p-tau burden and regional distribution in CTE compared to PART that might be helpful in differential diagnosis and reveal insights into disease pathogenesis.
Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations
Strand, Natalie , Maloney, Jillian , Wu, Samuel , Schneider, Rick , Char, Steven , Kraus, Molly, Gomez, Diego, Strand, Natalie H , Kraus, Molly B. , Schneider, Rick, Gomez, Diego A.

Mayo Clinic

Orthopedic Reviews | August 25, 2022 | Volume: 14 | Issue: 3 | Pages: No page available

10.52965/001c.37573 | PMID 36034726 Get It

Calciphylaxis is a serious and rare medical condition that leads to substantial clinical manifestations including pain, creating perioperative and treatment challenges. No standard treatment protocol exists nor are comprehensive guidelines available for perioperative management of patients with calciphylaxis. In this review, we evaluate existing literature (January 2000 to May 2021) with the aim to offer guidance for treating patients with this challenging disease through the perioperative period. Although no therapies are currently considered standard for treating calciphylaxis, multiple interventions are available for improving symptoms. Preoperative and intraoperative management involves monitoring and optimizing patient comorbid conditions and any possible electrolyte imbalances. Postoperative management can be challenging when potential calciphylaxis triggers are indicated, such as warfarin and corticosteroids. In addition, poor wound healing and difficult pain control are common. Therefore, a multifactorial approach to controlling postoperative pain is recommended that includes the use of nerve blocks, renal-sparing opioids, benzodiazepines, and/or ketamine. We present preoperative, intraoperative, and postoperative recommendations for treating calciphylaxis with levels of evidence when appropriate.